Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Encino. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Encino at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
This is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days), and a 6-week Treatment Period (during which participants will receive either NMRA-335140 or placebo). At the completion of the 6-week Treatment Period, participants who complete the study, provide informed consent, and
Sponsor: Neumora Therapeutics, Inc.
Check if you qualify for this major depressive disorder clinical trial in Encino, CA
If you're searching for major depressive disorder treatment options in Encino, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.